Skip to main content
ROIV logo

Roivant Sciences Ltd.

ROIVNASDAQHealthcareBiotechnology

$34.04Today:- (-)1Y +98.95%

As of Oct 15, 2026 close

Market cap
$24.54B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$16.41$42.50
Volume (live)
-
Avg. volume (3M)
7.73M

Roivant Sciences Ltd. (ROIV) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Roivant Sciences Ltd. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy
Based on 12 unique analysts
(15 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$46.64
+37.02% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ROIV Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Eve Burstein
Bernstein
BuyMaintains
$41.00
Chi Meng Fong
BofA Securities
HoldMaintains
$37.50 → $41.00
Brian Cheng
JP Morgan
BuyReiterates
-
Alex Thompson CFA
Stifel Nicolaus
BuyInitiates
$51.00
Unknown Analyst
Leerink Partners
BuyMaintains
$42.00 → $52.00
Yatin Suneja
Guggenheim
BuyReiterates
$42.00 → $46.00
Douglas Tsao
HC Wainwright
BuyInitiates Coverage
$47.00
Yaron Werber
TD Cowen
BuyInitiates Coverage
$50.00 → $55.00
Yatin Suneja
Guggenheim
BuyReiterates
$42.00 → $46.00
Douglas Tsao
HC Wainwright
BuyReiterates
$47.00
Dennis Ding
Jefferies
BuyMaintains
$42.00 → $52.00
Yaron Werber
TD Cowen
BuyReiterates
$50.00 → $55.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$40.00
Unknown Analyst
Jefferies
BuyMaintains
$42.00
Samantha Semenkow
Citi
BuyMaintains
$42.00 → $46.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 26, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ROIV?

The analyst consensus rating for ROIV is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for ROIV?

The average 12-month price target for ROIV is $46.64, representing an upside of 37.0% from the Oct 15, 2026 close of $34.04.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.